These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16874903)

  • 21. Treatment of acute coronary syndromes.
    Owen A
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11796858
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspirin and Plavix: what every clinical nurse specialist should know now.
    O'Malley P
    Clin Nurse Spec; 2007; 21(1):13-5. PubMed ID: 17213734
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 24. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 26. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.
    Berger PB
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():20A-29A. PubMed ID: 10745607
    [No Abstract]   [Full Text] [Related]  

  • 28. [The most important aspects of risk assessment].
    Wilhelm TJ; Post S
    Zentralbl Chir; 2013 Jun; 138(3):219-21. PubMed ID: 23967446
    [No Abstract]   [Full Text] [Related]  

  • 29. [Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
    Kim JH
    Korean J Gastroenterol; 2011 Apr; 57(4):205-6. PubMed ID: 21519172
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
    Granitskiĭ NA
    Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin and clopidogrel resistance.
    Fosburgh D
    Mayo Clin Proc; 2006 Jul; 81(7):989; author reply 990. PubMed ID: 16835978
    [No Abstract]   [Full Text] [Related]  

  • 34. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Johns A; Fisher M; Knappertz V
    Eur Heart J; 2006 Jul; 27(14):1754; author reply 1754-5. PubMed ID: 16751205
    [No Abstract]   [Full Text] [Related]  

  • 35. The charisma of subgroups and the subgroups of CHARISMA.
    Pfeffer MA; Jarcho JA
    N Engl J Med; 2006 Apr; 354(16):1744-6. PubMed ID: 16531617
    [No Abstract]   [Full Text] [Related]  

  • 36. Summaries for patients. What aspirin dose is safest and most effective for preventing heart disease?
    Ann Intern Med; 2009 Mar; 150(6):I-22. PubMed ID: 19293067
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticoagulation and antiaggregation in cardiac patients].
    Meyer BJ
    Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ticagrelor (Brilinta)--better than clopidogrel (Plavix)?
    Med Lett Drugs Ther; 2011 Sep; 53(1372):69-70. PubMed ID: 21897348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.
    Weber M; Bhatt DL; Brennan DM; Hankey GJ; Steinhubl SR; Johnston SC; Montalescot G; Mak KH; Fox KA; Easton DJ; Topol EJ; Hamm CW;
    Heart; 2011 Apr; 97(8):626-31. PubMed ID: 21393433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.